The score is primarily supported by strong financial performance—especially an improved FY2025 earnings profile and a very conservative balance sheet with minimal debt. Offsetting this, technicals are mixed with a negative MACD and the stock below key longer-term moving averages, and valuation is only moderately attractive with a ~24.5 P/E and low (~0.9%) dividend yield.
Positive Factors
Conservative balance sheet
Elimination of debt and a materially larger equity base provide durable financial flexibility: the company can fund investments, weather downturns, and pursue opportunistic M&A or product development without reliance on external borrowing, reducing long-term solvency risk.
Strong cash generation
Robust operating and free cash flow in the latest fiscal year indicates the business converts earnings into real cash, supporting sustainable reinvestment, potential shareholder returns, and organic growth funding. This strengthens strategic execution capacity over time.
High gross margins
Consistently elevated gross margins point to product pricing power or low incremental costs, enabling durable operating leverage. High gross margins give room for R&D and sales investment while preserving profit potential even if some pricing or cost pressure emerges.
Negative Factors
Earnings and cash volatility
Material year-to-year swings in margins and cash flow raise forecasting risk and indicate outcomes are sensitive to execution or timing of projects. This variability undermines predictability of returns and increases the operational burden to sustain improvements long term.
Inconsistent returns
Intermittent declines in return metrics suggest the company’s ROE and profitability are subject to cyclical or execution-driven swings rather than steady structural advantages, limiting confidence in sustained shareholder returns and indicating reliance on episodic performance gains.
Modest absolute scale
A relatively small revenue base constrains diversification, bargaining power, and economies of scale versus larger competitors. Scale limits reinvestment flexibility and increases sensitivity to loss of key customers or contracts, making long-term structural growth more execution-dependent.
Human Technologies,Inc. (5621) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥14.55B
Dividend Yield0.91%
Average Volume (3M)46.41K
Price to Earnings (P/E)18.0
Beta (1Y)1.45
Revenue Growth21.67%
EPS Growth13.55%
CountryJP
Employees306
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)25.90
Shares Outstanding9,593,200
10 Day Avg. Volume50,030
30 Day Avg. Volume46,413
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)3.39
Price to Sales (P/S)2.48
P/FCF Ratio15.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)101.3
Revenue Forecast (FY)¥7.48B
Human Technologies,Inc. Business Overview & Revenue Model
Company DescriptionHuman Technologies, Inc. develops and sells attendance management system. It offers KING OF TIME, a cloud-based attendance management system; DigitalPersona AD MFA, a PC authentication reinforcement system; DigitalPersona AD SSO, a single sign-on system; and Digital Persona SDK, a fingerprint authentication development kit. The company was founded in 2001 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHuman Technologies, Inc. primarily generates revenue through the sale of its products and services that are geared towards improving human productivity and efficiency. The company might have key revenue streams such as direct sales of their proprietary solutions, subscription or licensing fees for their technology platforms, and consulting services fees. Additionally, significant partnerships with corporate clients or technology providers could contribute to its earnings by expanding its market reach and enhancing its service offerings.
Human Technologies,Inc. Financial Statement Overview
Summary
Strong overall fundamentals: FY2025 profitability improved with expanding operating (~15.4%) and net (~10.8%) margins on rising revenue, supported by consistently high gross margin (~69–73%). Balance sheet is a major strength with debt effectively eliminated and higher equity, improving financial flexibility. Main risk is volatility, as margins and cash flow have been choppy year-to-year despite a strong latest period.
Income Statement
84
Very Positive
Profitability improved meaningfully in the latest annual period (FY2025): revenue rose to ~¥6.06B (up from ~¥5.03B in FY2024), while operating and net margins expanded to ~15.4% and ~10.8%, respectively (vs. ~10.0% and ~6.7% in FY2024). Gross margin remains very strong (~69–73%) across the period, supporting earnings leverage. The main watch-out is volatility: FY2022 showed higher margins than FY2023–FY2024, indicating profitability can swing year-to-year even as the revenue trajectory is positive.
Balance Sheet
92
Very Positive
The balance sheet is a clear strength: total debt is effectively eliminated in FY2025 (down from modest debt levels in prior years), resulting in very low financial risk and strong flexibility. Equity has grown materially (to ~¥4.43B in FY2025 from ~¥1.82–¥1.93B in FY2022–FY2023), and return on equity improved to ~14.8% in FY2025 (vs. ~8.6% in FY2024). A potential limitation is that returns are good but not consistently high (FY2024 dipped), suggesting performance is driven more by operating execution than leverage.
Cash Flow
78
Positive
Cash generation strengthened sharply in FY2025: operating cash flow rose to ~¥1.03B and free cash flow to ~¥1.00B, with free cash flow nearly matching net income (strong cash conversion versus FY2024). However, cash flow has been choppy—FY2024 saw weak free cash flow (~¥0.11B) and a decline versus FY2023, which raises some execution/working-capital volatility risk. Overall, the most recent year is strong, but the multi-year consistency is mixed.
Breakdown
TTM
Mar 2024
Mar 2024
Mar 2023
Mar 2022
Income Statement
Total Revenue
6.38B
6.06B
5.03B
4.22B
3.58B
Gross Profit
4.40B
4.18B
3.42B
3.00B
2.63B
EBITDA
1.12B
985.27M
533.38M
358.62M
622.76M
Net Income
731.26M
655.35M
335.43M
237.61M
438.63M
Balance Sheet
Total Assets
5.72B
5.89B
4.89B
2.98B
2.59B
Cash, Cash Equivalents and Short-Term Investments
3.71B
3.97B
3.32B
1.84B
1.63B
Total Debt
0.00
0.00
26.91M
251.42M
140.00M
Total Liabilities
1.20B
1.46B
995.60M
1.05B
776.54M
Stockholders Equity
4.52B
4.43B
3.89B
1.93B
1.82B
Cash Flow
Free Cash Flow
0.00
996.62M
111.18M
214.77M
166.69M
Operating Cash Flow
0.00
1.03B
398.08M
257.01M
263.93M
Investing Cash Flow
0.00
-234.42M
-285.92M
-41.54M
-90.04M
Financing Cash Flow
0.00
-142.02M
1.36B
-17.27M
-60.44M
Human Technologies,Inc. Technical Analysis
Technical Analysis Sentiment
Neutral
Last Price1895.00
Price Trends
50DMA
1715.82
Negative
100DMA
1879.66
Negative
200DMA
2084.79
Negative
Market Momentum
MACD
-76.06
Negative
RSI
45.35
Neutral
STOCH
59.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5621, the sentiment is Neutral. The current price of 1895 is above the 20-day moving average (MA) of 1514.85, above the 50-day MA of 1715.82, and below the 200-day MA of 2084.79, indicating a neutral trend. The MACD of -76.06 indicates Negative momentum. The RSI at 45.35 is Neutral, neither overbought nor oversold. The STOCH value of 59.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:5621.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025